新闻
IBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West Africa
IBA is pleased to announce that it has signed a contract for a Cyclone® KEY cyclotron with the International Atomic Energy Agency (IAEA). This cyclotron will be installed at the University Hospital of Reference in Cotonou Benin [...]
查看更多
LIVE WEBINAR 27/02 | Setting up a cyclotron radiopharmacy: Navigating the challenges through two case studies
Live Webinar on February 27th with Dr Richard Freifelder Setting up a cyclotron radiopharmacy: Navigating the challenges through two case […]
查看更多iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70
Successful completion of contractual site acceptance tests, with 70 MeV cyclotron now fully operational Louvain-la-Neuve, Belgium, January 23, 2024 – […]
查看更多IBA celebrates a new milestone with the sale of the 100th Cyclone® KIUBE cyclotron
Wednesday, December 20th, 2023 Louvain-la-Neuve, Belgium, December 20, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in […]
查看更多
WEBINAR | Will the approval of one or more AD drug unleash the use of amyloid PET imaging?
Listen the webinar on demand and be part of the forefront of PET imaging in Alzheimer's disease This interesting webinar […]
查看更多
Successful rigging of IBA's Cyclone® 30XP at POLATOM, Poland
We are happy to announce the successful rigging of our Cyclone® 30XP cyclotron at POLATOM that marks a significant milestone […]
查看更多IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease
Wednesday, December 13rd, 2023 Louvain-la-Neuve, Belgium, December 13, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), CMI Inc. and Life […]
查看更多IBA pioneers theranostic advancements, empowering the market to produce Astatine-211
Tuesday, December 12th, 2023 Rigging of the Cyclone® 30XP in Poland completed with a further two sites in Germany and […]
查看更多
Register for the learn & Talk session at SNMMI
Discover IBA's Learn and Talk sessions at SNMMI: Advantages and Disadvantages of 225Ac-PSMA therapy in Prostate Cancer Patients Prof. Sathkege […]
查看更多